The schizophrenia risk gene C4 induces pathological synaptic loss by impairing AMPAR trafficking

Rhushikesh A. Phadke(Boston University), Alison Brack(Boston University), Luke A. Fournier(Boston University), Ezra Kruzich(Boston University), Mingqi Sha(Boston University), Ines Picard(Boston University), Connor Johnson(Boston University), Dimitri Stroumbakis(Boston University), María Salgado(Boston University), Charlotte Yeung(Boston University), Berta Escude Velasco(Boston University), Yen Yu Liu(Boston University), Alberto Cruz‐Martín(Boston University)
Molecular Psychiatry
September 3, 2024
Cited by 17Open Access
Full Text

Abstract

Neuroimmune interactions play a significant role in regulating synaptic plasticity in both the healthy and diseased brain. The complement pathway, an extracellular proteolytic cascade, exemplifies these interactions. Its activation triggers microglia-dependent synaptic elimination via the complement receptor 3 (CR3). Current models of pathological complement activity in the brain propose that accelerated synaptic loss resulting from overexpression of C4 (C4-OE), a gene associated with schizophrenia, follows this pathway. Here, we report that C4-mediated cortical hypoconnectivity is CR3-independent. Instead, C4-OE triggers impaired GluR1 trafficking through an intracellular mechanism involving the endosomal protein SNX27, resulting in pathological synaptic loss. Moreover, C4 circuit alterations in the prefrontal cortex, a brain region associated with neuropsychiatric disorders, were rescued by increasing neuronal levels of SNX27, which we identify as an interacting partner of this neuroimmune protein. Our results link excessive complement activity to an intracellular endo-lysosomal trafficking pathway altering synaptic plasticity.


Related Papers

No related papers found

Powered by citation graph analysis